Central venous access devices in pediatric malignancies: A position paper of Italian association of pediatric hematology and oncology

Alessandro Crocoli, Assunta Tornesello, Mauro Pittiruti, Angelica Barone, Paola Muggeo, Alessandro Inserra, Angelo Claudio Molinari, Valeria Grillenzoni, Viviana Durante, Maria Pia Cicalese, Giulio Andrea Zanazzo, Simone Cesaro

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Introduction: Treatment of pediatric malignancies is becoming progressively more complex, implying the adoption of multimodal therapies. A reliable, long-lasting venous access represents one of the critical requirements for the success of those treatments. Recent technical innovations—such as minimally invasive procedures for placement, new devices and novel materials—have rapidly spread for clinical use in adult patients, but are still not consistently used in the pediatric population. Methods: The Supportive Therapy Working Group of Italian Association of Hematology and Oncology (AIEOP) reviewed medical literature focusing on new aspects of central venous access devices (VADs) in pediatric patients affected by oncohematological diseases. Results: Appropriate recommendations for clinical use in these patients have been discussed and formulated. Conclusions: The importance of the correct choice, management and use of VADs in pediatric oncohematological patients is a necessary prerequisite for an adequate standard of care, also considering the increased chances of cure and the longer life expectancy of those patients with modern therapies.

Original languageEnglish
Pages (from-to)130-136
Number of pages7
JournalJournal of Vascular Access
Volume16
Issue number2
DOIs
Publication statusPublished - Mar 1 2015

Fingerprint

Hematology
Pediatrics
Equipment and Supplies
Neoplasms
Therapeutics
Standard of Care
Group Psychotherapy
Life Expectancy
Population

Keywords

  • Central venous catheter
  • Hematology
  • Oncology
  • Pediatric malignancies
  • PICC
  • Port

ASJC Scopus subject areas

  • Surgery
  • Nephrology

Cite this

Central venous access devices in pediatric malignancies : A position paper of Italian association of pediatric hematology and oncology. / Crocoli, Alessandro; Tornesello, Assunta; Pittiruti, Mauro; Barone, Angelica; Muggeo, Paola; Inserra, Alessandro; Molinari, Angelo Claudio; Grillenzoni, Valeria; Durante, Viviana; Cicalese, Maria Pia; Zanazzo, Giulio Andrea; Cesaro, Simone.

In: Journal of Vascular Access, Vol. 16, No. 2, 01.03.2015, p. 130-136.

Research output: Contribution to journalArticle

@article{74c54484eb5b486cb43cf6d41fd5febc,
title = "Central venous access devices in pediatric malignancies: A position paper of Italian association of pediatric hematology and oncology",
abstract = "Introduction: Treatment of pediatric malignancies is becoming progressively more complex, implying the adoption of multimodal therapies. A reliable, long-lasting venous access represents one of the critical requirements for the success of those treatments. Recent technical innovations—such as minimally invasive procedures for placement, new devices and novel materials—have rapidly spread for clinical use in adult patients, but are still not consistently used in the pediatric population. Methods: The Supportive Therapy Working Group of Italian Association of Hematology and Oncology (AIEOP) reviewed medical literature focusing on new aspects of central venous access devices (VADs) in pediatric patients affected by oncohematological diseases. Results: Appropriate recommendations for clinical use in these patients have been discussed and formulated. Conclusions: The importance of the correct choice, management and use of VADs in pediatric oncohematological patients is a necessary prerequisite for an adequate standard of care, also considering the increased chances of cure and the longer life expectancy of those patients with modern therapies.",
keywords = "Central venous catheter, Hematology, Oncology, Pediatric malignancies, PICC, Port",
author = "Alessandro Crocoli and Assunta Tornesello and Mauro Pittiruti and Angelica Barone and Paola Muggeo and Alessandro Inserra and Molinari, {Angelo Claudio} and Valeria Grillenzoni and Viviana Durante and Cicalese, {Maria Pia} and Zanazzo, {Giulio Andrea} and Simone Cesaro",
year = "2015",
month = "3",
day = "1",
doi = "10.5301/jva.5000314",
language = "English",
volume = "16",
pages = "130--136",
journal = "Journal of Vascular Access",
issn = "1129-7298",
publisher = "Wichtig Publishing",
number = "2",

}

TY - JOUR

T1 - Central venous access devices in pediatric malignancies

T2 - A position paper of Italian association of pediatric hematology and oncology

AU - Crocoli, Alessandro

AU - Tornesello, Assunta

AU - Pittiruti, Mauro

AU - Barone, Angelica

AU - Muggeo, Paola

AU - Inserra, Alessandro

AU - Molinari, Angelo Claudio

AU - Grillenzoni, Valeria

AU - Durante, Viviana

AU - Cicalese, Maria Pia

AU - Zanazzo, Giulio Andrea

AU - Cesaro, Simone

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Introduction: Treatment of pediatric malignancies is becoming progressively more complex, implying the adoption of multimodal therapies. A reliable, long-lasting venous access represents one of the critical requirements for the success of those treatments. Recent technical innovations—such as minimally invasive procedures for placement, new devices and novel materials—have rapidly spread for clinical use in adult patients, but are still not consistently used in the pediatric population. Methods: The Supportive Therapy Working Group of Italian Association of Hematology and Oncology (AIEOP) reviewed medical literature focusing on new aspects of central venous access devices (VADs) in pediatric patients affected by oncohematological diseases. Results: Appropriate recommendations for clinical use in these patients have been discussed and formulated. Conclusions: The importance of the correct choice, management and use of VADs in pediatric oncohematological patients is a necessary prerequisite for an adequate standard of care, also considering the increased chances of cure and the longer life expectancy of those patients with modern therapies.

AB - Introduction: Treatment of pediatric malignancies is becoming progressively more complex, implying the adoption of multimodal therapies. A reliable, long-lasting venous access represents one of the critical requirements for the success of those treatments. Recent technical innovations—such as minimally invasive procedures for placement, new devices and novel materials—have rapidly spread for clinical use in adult patients, but are still not consistently used in the pediatric population. Methods: The Supportive Therapy Working Group of Italian Association of Hematology and Oncology (AIEOP) reviewed medical literature focusing on new aspects of central venous access devices (VADs) in pediatric patients affected by oncohematological diseases. Results: Appropriate recommendations for clinical use in these patients have been discussed and formulated. Conclusions: The importance of the correct choice, management and use of VADs in pediatric oncohematological patients is a necessary prerequisite for an adequate standard of care, also considering the increased chances of cure and the longer life expectancy of those patients with modern therapies.

KW - Central venous catheter

KW - Hematology

KW - Oncology

KW - Pediatric malignancies

KW - PICC

KW - Port

UR - http://www.scopus.com/inward/record.url?scp=84936771397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936771397&partnerID=8YFLogxK

U2 - 10.5301/jva.5000314

DO - 10.5301/jva.5000314

M3 - Article

C2 - 25362978

AN - SCOPUS:84936771397

VL - 16

SP - 130

EP - 136

JO - Journal of Vascular Access

JF - Journal of Vascular Access

SN - 1129-7298

IS - 2

ER -